تقرير
Severe Hypercalcemia Caused by Calcium-Alkali Syndrome after 15 Years of Postoperative Hypoparathyroidism in a Patient with Undiagnosed Hyperaldosteronism.
| العنوان: | Severe Hypercalcemia Caused by Calcium-Alkali Syndrome after 15 Years of Postoperative Hypoparathyroidism in a Patient with Undiagnosed Hyperaldosteronism. |
|---|---|
| المؤلفون: | Boufleuer ND; Hospital de Clínicas de Porto Alegre, Rua Ramiro Barcelos 2400, Zip Code 90035-903, Porto Alegre, RS, Brazil.; Internal Medicine Division, Hospital de Clínicas de Porto Alegre, Rua Ramiro Barcelos 2400, Zip Code 90035-903, Porto Alegre, RS, Brazil., Rados DV; Hospital de Clínicas de Porto Alegre, Rua Ramiro Barcelos 2400, Zip Code 90035-903, Porto Alegre, RS, Brazil.; Internal Medicine Division, Hospital de Clínicas de Porto Alegre, Rua Ramiro Barcelos 2400, Zip Code 90035-903, Porto Alegre, RS, Brazil.; Post-Graduate Program in Medical Sciences: Endocrinology, Universidade Federal do Rio Grande do Sul, Rua Ramiro Barcelos 2400, Zip Code 90035-903, Porto Alegre, RS, Brazil., Zambonato T; Hospital Moinhos de Vento, Porto Alegre, RS, Brazil., Maraschin CK; Universidade Federal do Rio Grande do Sul, Rua Ramiro Barcelos 2400, Zip Code 90035-903, Porto Alegre, RS, Brazil., Schaan BD; Hospital de Clínicas de Porto Alegre, Rua Ramiro Barcelos 2400, Zip Code 90035-903, Porto Alegre, RS, Brazil.; Internal Medicine Division, Hospital de Clínicas de Porto Alegre, Rua Ramiro Barcelos 2400, Zip Code 90035-903, Porto Alegre, RS, Brazil.; Post-Graduate Program in Medical Sciences: Endocrinology, Universidade Federal do Rio Grande do Sul, Rua Ramiro Barcelos 2400, Zip Code 90035-903, Porto Alegre, RS, Brazil.; Endocrine Division, Hospital de Clínicas de Porto Alegre, Rua Ramiro Barcelos 2400, Zip Code 90035-903, Porto Alegre, RS, Brazil.; National Institute of Science and Technology for Health Technology Assessment (IATS)-CNPq/Brazil, Rua Ramiro Barcelos 2350, Zip Code 90035-903, Porto Alegre, RS, Brazil. |
| المصدر: | Case reports in endocrinology [Case Rep Endocrinol] 2024 Feb 16; Vol. 2024, pp. 3067354. Date of Electronic Publication: 2024 Feb 16 (Print Publication: 2024). |
| نوع المنشور: | Case Reports |
| اللغة: | English |
| بيانات الدورية: | Publisher: Hindawi Pub. Corp Country of Publication: United States NLM ID: 101576457 Publication Model: eCollection Cited Medium: Print ISSN: 2090-6501 (Print) Linking ISSN: 2090651X NLM ISO Abbreviation: Case Rep Endocrinol Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: New York, NY : Hindawi Pub. Corp. |
| مستخلص: | Introduction: The triad of hypercalcemia, metabolic alkalosis, and acute kidney injury associated with ingesting high doses of calcium and absorbable bases characterizes the calcium-alkali syndrome. Clinical Case . We report the case of a patient with postthyroidectomy hypoparathyroidism 15 years ago due to differentiated thyroid cancer who presented with severe hypercalcemia. He had adequate control of calcemia for many years on treatment with calcitriol and calcium carbonate and hypertension treated with amlodipine, losartan, and hydrochlorothiazide. After a period of loss to follow-up, he suddenly presents with severe hypercalcemia, metabolic alkalosis, and loss of renal function. Upon hydration and withdrawal of calcitriol and calcium replacements, hypercalcemia resolved. The etiological investigation identified no granulomatous or neoplastic diseases, but an aldosterone-producing adrenal incidentaloma was found. The cause of hypercalcemia in this patient was calcium-alkali syndrome due to calcium carbonate replacement potentiated by hydrochlorothiazide and primary aldosteronism. Six months after the hospitalization and suspension of calcium and vitamin D, the patient returned to hypocalcemia, reinforcing the diagnosis. Conclusion: Although seldom described, the calcium-alkali syndrome is an expected complication for individuals with postoperative hypoparathyroidism, as they require lifelong calcium and vitamin D supplementation. This case also shows the importance of hydrochlorothiazide use and primary aldosteronism as possible triggers of life-threatening hypercalcemia. Competing Interests: The authors declare that they have no conflicts of interest. (Copyright © 2024 Natália Diel Boufleuer et al.) |
| References: | J Steroid Biochem Mol Biol. 2019 Oct;193:105434. (PMID: 31351131) J Am Soc Nephrol. 2010 Sep;21(9):1440-3. (PMID: 20413609) Proc (Bayl Univ Med Cent). 2013 Apr;26(2):179-81. (PMID: 23543983) Med Clin North Am. 2021 Nov;105(6):1065-1080. (PMID: 34688415) QJM. 2012 Dec;105(12):1209-12. (PMID: 21954111) Clin Endocrinol (Oxf). 2005 Nov;63(5):566-76. (PMID: 16268810) J Clin Endocrinol Metab. 2020 Jun 1;105(6):. (PMID: 32322899) Am J Nephrol. 2020;51(2):160-167. (PMID: 31968342) J Bone Miner Res. 1991 Oct;6 Suppl 2:S51-9; discussion S61. (PMID: 1763670) J Clin Endocrinol Metab. 2021 Oct 21;106(11):3113-3128. (PMID: 34240162) Clin Biochem. 2012 Aug;45(12):954-63. (PMID: 22569596) Metabolism. 2014 Jan;63(1):20-31. (PMID: 24095631) |
| تواريخ الأحداث: | Date Created: 20240226 Latest Revision: 20240227 |
| رمز التحديث: | 20240227 |
| مُعرف محوري في PubMed: | PMC10890900 |
| DOI: | 10.1155/2024/3067354 |
| PMID: | 38404648 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 2090-6501 |
|---|---|
| DOI: | 10.1155/2024/3067354 |